The angiographic catheters market has seen considerable growth due to a variety of factors.
• The market for angiographic catheters has experienced significant growth in the past years. The market size is predicted to increase from $1.29 billion in 2024 to $1.42 billion in 2025, showing a compound annual growth rate (CAGR) of 9.7%.
This notable growth in the past can be attributed to the escalating rates of cardiovascular diseases, elevated domestic income, increasing number of elderly people, a growing inclination towards minimally invasive operations, and government-led awareness campaigns.
The angiographic catheters market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the angiographic catheters market is predicted to experience robust growth. It is set to rise to $2.03 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%.
This projected growth in the upcoming period can be ascribed to factors such as a growing need for precise diagnostics, escalating healthcare spending, growth in online shopping for medical equipment, a rising instance of chronic illnesses, and the utilization of minimally invasive interventions. Key trends anticipated in this period entail technological innovation, increased R&D efforts, the application of AI in diagnosis, the progression of telemedicine, the surge in custom medications, and the broadening scope of outpatient treatment.
The angiographic catheters market is anticipated to expand due to the increasing frequency of heart surgeries. Cardiac surgery, which includes numerous operations on the heart and large vessels, is on the rise due to various factors such as population aging, the surge in cardiovascular illnesses, advancements in medical science, and improved surgical results. Angiographic catheters, utilized during these surgeries, aid in the visualization of coronary arteries, thereby facilitating efficient diagnosis and treatment of blockages or irregularities. For example, in August 2023, the National Health Service (NHS), a healthcare organization based in the UK, issued reports indicating that there were 215 heart transplant operations during the financial year of 2021-2022 in the UK, marking a 20% increase from the preceding year (2020-2021) when 179 operations took place. Hence, the augmentation in heart surgeries propels the growth of the angiographic catheters market.
The angiographic cathetersmarket covered in this report is segmented –
1) By Product: Conventional Catheters, Drug Eluting Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters
2) By Technology: X-Ray, Magnetic Resonance Angiography (MRA), Computed Tomography (CT)
3) By Application: Coronary, Endovascular, Neurology, Oncology, Other Applications
4) By End User: Hospital, Ambulatory Surgical Centers, Cardiac Centers, Brain Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Conventional Catheters: Diagnostic Catheters, Guiding Catheters, Balloon Catheters, Drug Eluting Balloon Catheters
2) By Drug Eluting Balloon Catheters: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons
3) By Cutting Balloon Catheters: Standard Cutting Balloons, Specialty Cutting Balloons
4) By Scoring Balloon Catheters: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons
Major players in the angiographic catheters market are prioritizing the development of innovative technologies such as the Fiber Optic RealShape (FORS) technology. This focus is in a bid to obtain real-time, high-resolution 3D imaging during catheter navigation, while minimizing radiation exposure and improving accuracy in intricate vascular procedures. FORS technology is a sophisticated imaging platform which leverages light reflected through optical fibers within medical devices. This action produces real-time, high-resolution 3D depictions of the devices’ forms within the body, thereby facilitating precise navigation in minimally invasive procedures. For instance, Philips Healthcare, a health technology firm based in the Netherlands, unveiled the LumiGuide in February 2024. This system guides catheters using light radiation-free methods in endovascular aortic procedures. Leveraging FORS technology, LumiGuide produces real-time, high-resolution, 3D visuals of devices within the body, eliminating the need for X-ray angiography. Noteworthy features of the LumiGuide include improved 3D imaging of catheters, lower levels of radiation exposure, instantaneous device orientation feedback, and artificial intelligence-assisted registration for enhanced precision in complicated procedures. Available in selected hospitals in Europe and the U.S., LumiGuide aims to enhance patient safety and procedural efficiency.
Major companies operating in the angiographic catheters market are:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• Becton Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Terumo Corporation
• Nipro Corporation
• Cook Medical Inc.
• Teleflex Incorporated
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology (Beijing) Co Ltd.
• Merit Medical Systems Inc.
• Cordis Corporation
• MicroPort Scientific Corporation
• Asahi Intecc Co Ltd.
• AngioDynamics Inc.
• Biosensors International Group Ltd.
• Alvimedica Medical Technologies
• BrosMed Medical Co Ltd.
• iVascular SLU
• Reva Medical Inc.
North America was the largest region in the angiographic catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.